
Charvi Kalal
PharmD
Charvi Kalal is a Pharm.D intern and aspiring medical writer with hands-on experience in medical writing, clinical research, pharmacovigilance, and clinical pharmacy. She has experience in medical content writing through CliMed, along with exposure to ADR monitoring, prescription analysis, patient counselling, literature review, and research documentation. Her research focuses on ADR monitoring and reporting in breast cancer patients receiving targeted therapy. With certifications in GCP, biomedical research, scientific writing, and clinical research, she is passionate about transforming scientific evidence into accurate, engaging, and accessible healthcare content.
About Charvi
Charvi Kalal (PharmD) is a writer at Pharmacally, with 44 published articles, each checked against primary sources by our editorial team.
Articles by Charvi Kalal
Health TidingsBeacon’s Laru-Zova Meets Primary LLVA Endpoint in X-Linked Retinitis Pigmentosa
New Drug ApprovalSogroya Gets Positive EU Opinion for Idiopathic Short Stature
Clinical TrialsRoche’s Lunsumio Combination Improves Progression-Free Survival in Phase III CELESTIMO Trial
Clinical TrialsSKY-0515 Shows 1.59-Point cUHDRS Benefit in Huntington’s Disease
Clinical TrialsTRUTAKNA Stabilized Kidney Function and Reduced Risk of Kidney Disease Progression Through Two Years in ORIGIN 3
Clinical TrialsZipalertinib Plus Chemotherapy Improves Progression-Free Survival in First-Line EGFR Exon 20 Insertion-Positive NSCLC
Clinical TrialsStructure Advances Oral Obesity Pipeline With ACCG-2671 and Aleniglipron Data
Clinical TrialsVOXZOGO (Vosoritide) Shows Significant Growth Improvements in Phase 3 Hypochondroplasia Trial
A. Musharaf Mohammad
Aabha Dey
Aasritha Thippavajjala